NeuBase Therapeutics Inc (NBSE)
0.378
0.00 (0.00%)
USD |
NASDAQ |
May 16, 16:00
NeuBase Therapeutics Accounts Payable (Quarterly): 0.2586M for Sept. 30, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 0.2586M |
| June 30, 2023 | 0.3221M |
| March 31, 2023 | 0.5902M |
| December 31, 2022 | 0.3695M |
| September 30, 2022 | 1.843M |
| June 30, 2022 | 1.656M |
| March 31, 2022 | 1.621M |
| December 31, 2021 | 1.194M |
| September 30, 2021 | 1.808M |
| June 30, 2021 | 1.520M |
| March 31, 2021 | 2.176M |
| December 31, 2020 | 1.178M |
| September 30, 2020 | 1.505M |
| June 30, 2020 | 1.310M |
| March 31, 2020 | 1.664M |
| December 31, 2019 | 1.366M |
| September 30, 2019 | 1.477M |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | 0.0217M |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 |
| Date | Value |
|---|---|
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | 1.192M |
| September 30, 2014 | |
| June 30, 2014 | 6.658M |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | |
| September 30, 2011 | |
| June 30, 2011 |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.2586M
Minimum
Sep 2023
2.176M
Maximum
Mar 2021
1.286M
Average
1.477M
Median
Sep 2019
Accounts Payable (Quarterly) Benchmarks
| Ampio Pharmaceuticals Inc | 0.75M |
| Stoke Therapeutics Inc | 2.102M |
| ABVC BioPharma Inc | -- |
| MAIA Biotechnology Inc | 1.638M |
| Aprea Therapeutics Inc | 1.318M |